查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790474

美国临床试验设备和辅助解决方案市场规模、份额和趋势分析报告：按类型、阶段和细分市场预测，2025 年至 2033 年

U.S. Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Analysis Report By Type (Sourcing, Supply/Logistics, Service), By Phase (Phase I, II, III, IV), And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

市场规模与趋势：

美国临床试验设备和辅助解决方案市场规模预计在 2024 年达到 10.5 亿美元，预计到 2033 年将达到 20.6 亿美元，2025 年至 2033 年的复合年增长率为 7.83%。

这一增长是由日益复杂的临床试验通讯协定推动的，这增加了对设备物流精准性、设备校准以及研究相关物资及时分发的需求。申办方面临着遵守法规和研究时间表的压力，这导致他们越来越依赖专门从事辅助供应链管理、配套、设备租赁和逆向物流的第三方供应商。

美国的临床试验正日益分散，推动了对设备和辅助解决方案的需求。传统的集中式临床试验正在被混合和完全分散的模式所取代或补充，需要在参与者家中和现场进行广泛的物流协调和专门设备部署。这种转变需要直接面向患者 (DTP) 的供应链、行动医疗套件、连网医疗设备和必须符合 FDA 标准的家庭诊断设备。例如，远端心电图监测仪、穿戴式生物感测器和数位肺计量计的兴起需要能够远端管理设备校准、患者培训和数据整合的辅助提供者。支援多个远端站点和参与者的物流复杂性需要即时追踪、自动补给系​​统和强大的逆向物流。所有这些都刺激了对提供针对分散试验量身定制的端到端支援的辅助解决方案供应商的投资。

精准医疗和复杂治疗领域（如肿瘤学、神经病学和基因治疗）临床试验的激增也推动了美国临床试验设备和辅助解决方案产业的成长。这些试验通常需要高度专业化的设备，例如细胞治疗输液帮浦、客製化检体采集套件和温控药物传输装置。辅助设备供应商需要处理专门的包装、设备预处理和维护通讯协定，以保持温度和时间敏感型供应的完整性。随着通讯协定变得越来越复杂，包括生物标记评估、数位端点和纵向采样，辅助服务的标准化和扩充性变得至关重要。为此，供应商正在整合云端基础管理、自动标籤和合规性追踪工具，以简化流程并满足赞助商和 CRO 日益增长的需求。与先进治疗试验的这种合作正在将市场从基础物流扩展到高价值的临床试验支援基础设施。

目录

第一章调查方法与范围

第二章执行摘要

第 3 章美国临床试验设备和辅助解决方案市场：变数、趋势和范围

  • 市场体系展望
  • 美国临床试验设备与辅助解决方案市场动态
  • 技术格局
  • 定价模式分析
  • 美国临床试验设备与辅助解决方案市场：分析工具

第四章：美国临床试验设备和辅助解决方案市场：类型估计和趋势分析

  • 细分仪表板
  • 美国临床试验设备与辅助解决方案市场类型变化分析
  • 美国临床试验设备和辅助解决方案市场规模和趋势分析（按类型）（2021-2033）
  • 采购
    • 采购
    • 租赁
  • 供应/物流
    • 运输
    • 包装
    • 其他的
  • 服务
    • 校准
    • 设备维护
    • 其他的
  • 其他的

第五章美国临床试验设备和辅助解决方案市场：阶段估计和趋势分析

  • 细分仪表板
  • 美国临床试验设备和辅助解决方案市场的阶段波动分析
  • 美国临床试验设备和辅助解决方案市场规模和趋势分析（按阶段，2021-2033）
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第六章 竞争态势

  • 公司分类
    • 市场领导者
    • 新兴企业
  • 2024 年公司市场占有率/估值分析
  • 公司简介
    • Ancillare, LP
    • Imperial CRS, Inc.
    • Woodley Equipment Company Ltd.
    • Thermo Fisher Scientific, Inc.
    • Parexel International（MA）Corporation
    • Emsere（formerly MediCapital Rent）
    • Quipment SAS
    • IRM
    • Marken（UPS-United Parcel Service）
    • Myonex
    • Yourway
Product Code: GVR-4-68040-686-6

Market Size & Trends:

The U.S. clinical trial equipment & ancillary solutions market size was estimated at USD 1.05 billion in 2024 and is projected to reach USD 2.06 billion by 2033, growing at a CAGR of 7.83% from 2025 to 2033. The growth is due to the increasing complexity of clinical trial protocols, which has heightened the need for precision in equipment logistics, device calibration, and timely distribution of trial-related supplies. Sponsors are under growing pressure to meet tight regulatory and study timelines, which in turn has increased reliance on third-party providers specializing in ancillary supply chain management, kitting, equipment leasing, and reverse logistics.

The increasing decentralization of clinical trials in the U.S. is a major driver for the demand for equipment and ancillary solutions. Traditional centralized trials are being replaced or supplemented by hybrid and fully decentralized models, which require extensive logistical coordination and specialized equipment deployment at participants' homes or local sites. This shift has created a need for direct-to-patient (DTP) supply chains, mobile health kits, connected medical devices, and home-use diagnostics that must be compliant with FDA standards. For instance, the rise of remote ECG monitors, wearable biosensors, and digital spirometers has necessitated ancillary providers capable of managing device calibration, patient training, and data integration remotely. The logistical complexity of supporting multiple remote sites and participants requires real-time tracking, automated resupply systems, and robust reverse logistics - all of which are fueling investments into ancillary solution providers offering end-to-end support tailored for decentralized trials.

The surge in precision medicine and complex therapeutic areas such as oncology, neurology, and gene therapy trials is also propelling the growth of the clinical trial equipment & ancillary solutions industry in the U.S. These trials often demand highly specific equipment like infusion pumps for cellular therapies, customized specimen collection kits, and temperature-controlled drug delivery devices. Ancillary providers are expected to handle specialized packaging, pre-conditioning of equipment, and maintenance protocols to preserve the integrity of temperature- and time-sensitive supplies. The increase in protocol complexity - including biomarker assessments, digital endpoints, and longitudinal sampling - has made the standardization and scalability of ancillary services critical. In response, vendors are integrating cloud-based inventory management, automated labeling, and compliance-tracking tools to streamline processes and meet the heightened demands of sponsors and CROs. This alignment with advanced therapeutic trials is expanding the market beyond basic logistics into high-value clinical trial support infrastructure.

U.S. Clinical Trial Equipment & Ancillary Solutions Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. clinical trial equipment & ancillary solutions market report based on type, and phase:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Sourcing
    • Procurement
    • Equipment
    • Ancillaries
    • Rental
    • Equipment
    • Ancillaries
  • Supply/Logistics
    • Transportation
    • Packaging
    • Others
  • Service
    • Calibrations
    • Equipment servicing
    • Others
  • Others
  • Phase Outlook (Revenue, USD Million, 2021 - 2033)
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Value chain based analysis (Model 2)
    • 1.7.3. Multivariate Analysis (Model 3)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Clinical Trial Equipment & Ancillary Solutions Market: Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. U.S. Clinical Trial Equipment & Ancillary Solutions Market Dynamics
    • 3.2.1. Market Driver Impact Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Technological Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. U.S. Clinical Trial Equipment & Ancillary Solutions Market: Analysis Tools
    • 3.5.1. Porter's Five Forces Analysis
    • 3.5.2. PESTEL Analysis

Chapter 4. U.S. Clinical Trial Equipment & Ancillary Solutions Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Clinical Trial Equipment & Ancillary Solutions Market Type Movement Analysis
  • 4.3. U.S. Clinical Trial Equipment & Ancillary Solutions Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. Sourcing
    • 4.4.1. Sourcing Market Estimates and Forecasts, 2021 - 2033 (USD million)
    • 4.4.2. Procurement
      • 4.4.2.1. Procurement Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.2. Equipment
        • 4.4.2.2.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.3. Ancillaries
        • 4.4.2.3.1. Ancillaries Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Rental
      • 4.4.3.1. Rental Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2. Equipment
        • 4.4.3.2.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.3. Ancillaries
        • 4.4.3.3.1. Ancillaries Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Supply/Logistics
    • 4.5.1. Supply/Logistics Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Transportation
      • 4.5.2.1. Transportation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Packaging
      • 4.5.3.1. Packaging Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Service
    • 4.6.1. Service Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Calibrations
      • 4.6.2.1. Calibrations Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Equipment servicing
      • 4.6.3.1. Equipment Servicing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Others
      • 4.6.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Clinical Trial Equipment & Ancillary Solutions Market: Phase Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Clinical Trial Equipment & Ancillary Solutions Market Phase Movement Analysis
  • 5.3. U.S. Clinical Trial Equipment & Ancillary Solutions Market Size & Trend Analysis, by Phase, 2021 to 2033 (USD Million)
  • 5.4. Phase I
    • 5.4.1. Phase I Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Phase II
    • 5.5.1. Phase II Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Phase III
    • 5.6.1. Phase III Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Phase IV
    • 5.7.1. Phase IV Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
    • 6.1.1. Market Leaders
    • 6.1.2. Emerging Players
  • 6.2. Company Market Share/Assessment Analysis, 2024
  • 6.3. Company Profiles
    • 6.3.1. Ancillare, LP
      • 6.3.1.1. Company overview
      • 6.3.1.2. Financial performance
      • 6.3.1.3. Service benchmarking
      • 6.3.1.4. Strategic initiatives
    • 6.3.2. Imperial CRS, Inc.
      • 6.3.2.1. Company overview
      • 6.3.2.2. Financial performance
      • 6.3.2.3. Service benchmarking
      • 6.3.2.4. Strategic initiatives
    • 6.3.3. Woodley Equipment Company Ltd.
      • 6.3.3.1. Company overview
      • 6.3.3.2. Financial performance
      • 6.3.3.3. Service benchmarking
      • 6.3.3.4. Strategic initiatives
    • 6.3.4. Thermo Fisher Scientific, Inc.
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Service benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Parexel International (MA) Corporation
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Service benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Emsere (formerly MediCapital Rent)
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Service benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Quipment SAS
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Service benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. IRM
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Service benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. Marken (UPS-United Parcel Service)
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Service benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Myonex
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Service benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Yourway
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Service benchmarking
      • 6.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. clinical trial equipment & ancillary solutions market, by region, 2021 - 2033 (USD Million)
  • Table 3 U.S. clinical trial equipment & ancillary solutions market, by product, 2021 - 2033 (USD Million)
  • Table 4 U.S. clinical trial equipment & ancillary solutions market, by phase, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 US clinical trial equipment & ancillary solutions market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Value-Chain-Based Sizing & Forecasting
  • Fig. 9 QFD model sizing & forecasting
  • Fig. 10 Bottom-up approach
  • Fig. 11 Market snapshot
  • Fig. 12 Segment snapshot
  • Fig. 13 Segment snapshot
  • Fig. 14 Segment snapshot
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Parent market outlook, 2024 (USD Million)
  • Fig. 17 Ancillary market outlook, 2024 (USD Million)
  • Fig. 18 US clinical trial equipment & ancillary solutions market dynamics
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 PESTEL analysis
  • Fig. 21 U.S. clinical trial equipment & ancillary solutions market type outlook: Segment dashboard
  • Fig. 22 U.S. clinical trial equipment & ancillary solutions market, by type segment: Market share, 2024 & 2033
  • Fig. 23 Sourcing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Procurement market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Ancillaries market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Rental market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Equipment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Ancillaries market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Supply/Logistics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Transportation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Packaging market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Service market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Calibrations market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Equipment servicing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 US clinical trial equipment & ancillary solutions market phase outlook: Segment dashboard
  • Fig. 39 US clinical trial equipment & ancillary solutions market, by phase segment: Market share, 2024 & 2033
  • Fig. 40 Phase I market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Phase II market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Phase III market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Phase IV market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Market participant categorization
  • Fig. 45 Heat map analysis